Contact this trialFirst, we need to learn more about you.
Radiopharmaceutical
Lutetium (177Lu) Vipivotide Tetraxetan for Prostate Cancer
Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial aims to test the effectiveness and safety of a drug called lutetium (177Lu) vipivotide tetraxetan (AAA617) in patients with prostate cancer that has spread
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service